Tara Kendall

583 total citations
16 papers, 382 citations indexed

About

Tara Kendall is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Tara Kendall has authored 16 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Tara Kendall's work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Treatment and Pharmacology (5 papers). Tara Kendall is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Treatment and Pharmacology (5 papers). Tara Kendall collaborates with scholars based in United States and France. Tara Kendall's co-authors include Sudha Sud, Margaret R. Gyetko, Jennifer Fuller, Michael W. Newstead, Theodore J. Standiford, Karim Khan, John E. Foker, Kirsti Catton, Andrzej Jakubowiak and Mark Kaminski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Tara Kendall

16 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Kendall United States 9 186 169 102 97 84 16 382
YH Park South Korea 9 59 0.3× 81 0.5× 168 1.6× 44 0.5× 56 0.7× 34 367
Christine‐Ivy Liacos Greece 12 94 0.5× 178 1.1× 91 0.9× 71 0.7× 39 0.5× 33 509
J.M. Tourani France 7 49 0.3× 63 0.4× 127 1.2× 54 0.6× 62 0.7× 17 378
Juhani Vartiainen Finland 11 37 0.2× 93 0.6× 78 0.8× 44 0.5× 25 0.3× 15 343
Alexander K. Stewart United States 5 293 1.6× 204 1.2× 135 1.3× 26 0.3× 23 0.3× 8 417
Keiko Kagami Japan 11 129 0.7× 130 0.8× 80 0.8× 30 0.3× 55 0.7× 37 379
C Cabrol Switzerland 11 201 1.1× 104 0.6× 35 0.3× 22 0.2× 17 0.2× 34 363
Heidrun Boztug Austria 13 208 1.1× 81 0.5× 85 0.8× 37 0.4× 41 0.5× 24 529
Joseena Iype Switzerland 9 59 0.3× 93 0.6× 43 0.4× 33 0.3× 18 0.2× 12 379
Masaaki Kume Japan 11 240 1.3× 242 1.4× 80 0.8× 134 1.4× 23 0.3× 27 543

Countries citing papers authored by Tara Kendall

Since Specialization
Citations

This map shows the geographic impact of Tara Kendall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Kendall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Kendall more than expected).

Fields of papers citing papers by Tara Kendall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Kendall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Kendall. The network helps show where Tara Kendall may publish in the future.

Co-authorship network of co-authors of Tara Kendall

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Kendall. A scholar is included among the top collaborators of Tara Kendall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Kendall. Tara Kendall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jakubowiak, Andrzej, Tara Kendall, Ammar Al-Zoubi, et al.. (2009). Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma. Journal of Clinical Oncology. 27(30). 5015–5022. 57 indexed citations
2.
Hofmeister, Craig C., Erica Campagnaro, Tara Kendall, et al.. (2009). A268 Phase I/II Trial of Lenalidomide, Bortezomib, Doxil, and Dexamethasone in Front-Line Multiple Myeloma. Clinical Lymphoma & Myeloma. 9. S45–S46. 2 indexed citations
3.
Hideshima, Teru, Peter Sportelli, Lawrence B. Gardner, et al.. (2009). A347 Phase I Trial of Perifosine, Lenalidomide, and Dexamethasone in Relapsed or Refractory Myeloma. Clinical Lymphoma & Myeloma. 9. S56–S57. 3 indexed citations
4.
Jakubowiak, Andrzej, Malathi Hari, Tara Kendall, et al.. (2008). Elimination of CD20-Expressing Cells in Multiple Myeloma by Iodine I-131 Tositumomab (Bexxar®) Correlates with Response to Therapy. Blood. 112(11). 5176–5176. 2 indexed citations
5.
6.
Jakubowiak, Andrzej, Paul G. Richardson, Todd M. Zimmerman, et al.. (2008). Phase I Results of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (MM). Blood. 112(11). 3691–3691. 18 indexed citations
7.
8.
9.
10.
Jakubowiak, Andrzej, Malathi Hari, Ammar Al-Zoubi, et al.. (2007). Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).. Blood. 110(11). 4796–4796. 1 indexed citations
11.
Khan, Karim, Arash Sabati, Tara Kendall, & John E. Foker. (2006). The Effect of Traction on Esophageal Structure in Children with Long-Gap Esophageal Atresia. Digestive Diseases and Sciences. 51(11). 1917–1921. 11 indexed citations
12.
Jakubowiak, Andrzej, et al.. (2006). A phase II study of combination of bortezomib, liposomal doxorubin, and dexamethasone (VDD) as first line therapy for multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 17504–17504. 2 indexed citations
13.
14.
Foker, John E., Tara Kendall, Kirsti Catton, & Karim Khan. (2005). A flexible approach to achieve a true primary repair for all infants with esophageal atresia. Seminars in Pediatric Surgery. 14(1). 8–15. 58 indexed citations
15.
Jakubowiak, Andrzej, et al.. (2005). Combination Therapy with Velcade, Doxil, and Dexamethasone (VDD) for Patients with Relapsed/Refractory Multiple Myeloma (MM).. Blood. 106(11). 5179–5179. 18 indexed citations
16.
Gyetko, Margaret R., Sudha Sud, Tara Kendall, et al.. (2000). Urokinase Receptor-Deficient Mice Have Impaired Neutrophil Recruitment in Response to Pulmonary Pseudomonas aeruginosa Infection. The Journal of Immunology. 165(3). 1513–1519. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by YH Park Breakdown of academic impact, for papers by Christine‐Ivy Liacos Breakdown of academic impact, for papers by J.M. Tourani Breakdown of academic impact, for papers by Juhani Vartiainen Breakdown of academic impact, for papers by Alexander K. Stewart Breakdown of academic impact, for papers by Keiko Kagami Breakdown of academic impact, for papers by C Cabrol Breakdown of academic impact, for papers by Heidrun Boztug Breakdown of academic impact, for papers by Joseena Iype Breakdown of academic impact, for papers by Masaaki Kume
Rankless by CCL
2026